Independent report
Flu vaccines 2025 to 2026: JCVI advice
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about vaccines for the 2025 to 2026 flu season.
Documents
Details
This document sets out JCVI’s scientific view on the use of flu vaccines in the UK for the 2025 to 2026 flu season.
Updates to this page
Published 17 July 2024Last updated 3 December 2024 + show all updates
-
The JCVI Influenza vaccine advice for 2025 to 2026 has been updated to reflect that the trivalent formulation of IIVa has now been granted a change in license indication for use from the age of 50 years of age. The statement has also been simplified for at-risk adults into one age band, 18 to 64 years of age.
-
First published.